- The US Food and Drug Administration (FDA) on Wednesday authorized a revamped version of the COVID-19 booster shot from the two big pharmaceutical companies providing the vaccine in the US, Moderna and BioNTech-Pfizer.
- The US has purchased more than 170 million doses of the boosters from the two companies with the hopes of preventing another significant wave of infections as the seasons change and people are forced indoors.
- In the US, half of those who received the first two doses of the COVID vaccine received the first recommended booster dose.
COVID: US authorities approve updated booster shots targeting omicron 31.08.2022
